Instalab
logoInstalab

Atlantic Cod (Gad m 1) IgE

Blood Test
Your most precise read on cod allergy risk, beyond what generic fish testing can tell you.
4.8 (4,236 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Atlantic Cod (Gad m 1) IgE test?

This test is most useful if any of these apply to you.

Reacted to Fish Before
You've had hives, swelling, or worse after eating fish and want to know whether cod and related species are the real culprit.
Allergic to One Fish, Curious About Others
You know you react to one fish species and want to map which others are likely safe to keep on your plate.
Living With Severe Atopic Disease
You have eczema, asthma, or multiple food allergies and want clarity on whether fish belongs on your safe-foods list.
Parent of a Child With Seafood Reactions
Your child reacted to fish and you need a precise read on cod allergy risk before deciding what to keep in the kitchen.

About Atlantic Cod (Gad m 1) IgE

If you've had a reaction to fish but don't know which species are safe to eat, this test gives you a sharper answer than a basic cod test can. Gad m 1 (the scientific name for the main allergy-causing protein in Atlantic cod, called parvalbumin) is a dominant fish allergen, and it shows up in many species beyond cod, so measuring antibodies to this one protein helps predict reactions to a wide range of fish.

Cod allergy is one of the more common fish allergies, and reactions can range from hives to full anaphylaxis. Knowing whether you carry IgE (immunoglobulin E, the antibody your body produces during an allergic response) specifically against Gad m 1 helps map your true risk profile in a way that older whole-extract tests cannot.

What This Test Actually Measures

A whole-cod extract test looks for IgE against a mixture of cod proteins. This test isolates one protein, Gad m 1, the small heat-stable parvalbumin that sits in fish muscle and survives cooking and digestion. Because parvalbumin is the protein family most commonly responsible for fish allergy across species, antibodies to Gad m 1 often reflect a broad form of fish sensitivity rather than a quirk specific to cod, though about a third of fish-allergic patients are not sensitized to Gad m 1 at all.

This is called component-resolved testing. Instead of asking whether your immune system reacts to anything in cod, it asks whether it reacts to a specific molecule that drives much of clinical fish allergy. That precision matters because some people are allergic to cod but not to parvalbumin, and others are allergic to parvalbumin but happened to be tested only against cod.

Diagnosing Cod Allergy

When the test result is interpreted against an actual food challenge, the numbers translate into high diagnostic accuracy. In a study of Korean children with suspected seafood allergy, cod-specific IgE measured against the gold standard of oral food challenge showed strong ability to separate allergic from non-allergic children (AUC stands for area under the curve, a way of summarizing how well a test separates allergic from non-allergic people, where 1.0 is perfect and 0.5 is no better than a coin flip). The test caught most of the truly allergic children and correctly cleared most of the non-allergic ones.

Recombinant Gad c 1, a Baltic cod parvalbumin that is essentially the same protein as Gad m 1 under a different naming convention, performed better than crude cod extract in classifying cod allergy in one pediatric study. At higher IgE levels, the test predicted cod allergy on food challenge with high probability, which can be sufficient that some people may reasonably avoid a formal challenge.

Cross-Reactivity Across Fish Species

Parvalbumin is structurally similar across many fish. People who are clinically allergic to cod often show antibody cross-reactivity to mackerel, herring, and plaice, suggesting these fish share a common molecular structure. IgE against fish parvalbumin can even cross-react with frog parvalbumin, which has caused anaphylaxis in fish-allergic people who later ate frog meat.

Clinical allergenicity varies by species. A 2025 fish allergenicity ladder validated against food challenge data placed cod, salmon, tuna, and halibut in the least allergenic tier, herring and grouper in a moderately allergenic tier, and catfish, grass carp, and tilapia in the most allergenic tier. Older work based on purified parvalbumin cross-reactivity ranked cod higher, but parvalbumin content data show that salmon and tuna actually contain very little parvalbumin. This is why a single Gad m 1 result paired with parvalbumin testing from other species can guide which fish you might safely add back to your diet.

Anaphylaxis and Symptom Patterns

Fish allergy reactions span hives, swelling, gastrointestinal distress, and anaphylaxis. In one Spanish cohort of fish-allergic patients, only a minority had IgE to cod parvalbumin even though all had clear clinical fish allergy. Myosin light chain was the most frequently recognized allergen in that cohort, and patients sensitized only to myosin light chain tended to present with urticaria, angioedema, or anaphylaxis.

What this means is that a positive Gad m 1 result is meaningful, but a negative result does not rule out clinically important fish allergy. Up to about 38% of fish-allergic patients in a multinational cohort were negative to cod parvalbumin, and some people react through other fish proteins entirely, including enolase, aldolase, and myosin light chain, none of which are captured by the Gad m 1 test alone.

What Gad m 1 Adds That Standard Tests Miss

Crude fish extract IgE can be sensitive but is often poor at telling species apart. In one adult study, cod extract IgE caught most cod-allergic adults but had low specificity for distinguishing cod allergy from allergy to other fish. Component testing fills this gap: Gad m 1 marks parvalbumin-driven fish allergy, while testing for enolase or aldolase identifies people with non-parvalbumin profiles who might otherwise be missed. In multiplex component testing of fish-allergic patients, about 63% were positive to Gad m 1 specifically, while around 93% reacted to at least one fish parvalbumin across species.

Across food allergies generally, a meta-analysis of diagnostic tests found that skin prick testing and specific IgE to whole extracts have high sensitivity, while specific IgE to individual protein components and the basophil activation test have higher specificity. In practical terms, Gad m 1 narrows the question from "are you sensitized to something in cod" to "are you sensitized to a protein commonly linked to systemic reactions."

When Results Can Be Misleading

Sensitization is not the same as allergy. A positive Gad m 1 IgE means your immune system has produced antibodies to the protein, but only a portion of sensitized people actually react when they eat it. Europe-wide data show food allergy prevalence around 13% when measured by IgE positivity or skin prick test, but lower when confirmed by clinical history or food challenge.

  • A negative cod extract test does not rule out Gad m 1 sensitization: in fish-allergic adults, only a minority of cod-allergic patients have positive IgE to cod parvalbumin specifically, and the pattern of which fish proteins drive reactions varies widely between individuals.
  • Cross-reactive IgE can confuse interpretation: parvalbumin in cod shares molecular structure with parvalbumin in many other fish and even frogs, so a positive Gad m 1 result does not necessarily mean cod is the only or even main trigger.
  • A small sample of the molecule's variants are detected: some Gad m 1 variants and other cod allergens like enolase and aldolase fall outside the standard parvalbumin assay, so a negative result does not rule out cod allergy through alternative proteins.
  • Total IgE level affects interpretation: people with very high overall IgE due to atopic disease may show low-level positivity to many allergens without true clinical reactivity, while people with low total IgE may have meaningful sensitization at lower numeric thresholds.

Tracking Your Trend

A single Gad m 1 result is a snapshot. For people with confirmed fish allergy, IgE levels can drift over time, sometimes declining naturally and sometimes responding to treatment. Get a baseline, then retest annually if you are not under active treatment, or every 3 to 6 months if you are undergoing allergen immunotherapy where IgE typically rises before it falls.

Trends matter more than a single number. A falling Gad m 1 IgE over multiple readings can support a conversation with your allergist about a supervised reintroduction trial. A stable or rising number supports continued avoidance and emergency preparedness. Without serial measurements, you cannot tell which trajectory you are on.

Decision Pathway for Unexpected Results

If your Gad m 1 IgE is positive but you have never reacted to fish, the next step is not avoidance by default. Sensitization without symptoms is common, and confirming clinical allergy requires either a careful history of reactions, a supervised oral food challenge, or in some cases a basophil activation test. Pair the result with testing for parvalbumin from other species (such as salmon Sal s 1, carp Cyp c 1, or tuna Thu a 1) to map which fish carry the highest risk for you.

If your Gad m 1 IgE is negative but you have had clear reactions to cod or other fish, ask for component testing of enolase (Gad m 2) and aldolase (Gad m 3), which can be the driver in parvalbumin-negative profiles. An allergist familiar with component-resolved diagnosis can build a panel that captures the cause of your reactions, not just the most common culprit. Total IgE, skin prick testing with fish extracts, and a basophil activation test all add complementary information.

What Moves This Biomarker

Evidence-backed interventions that affect your Atlantic Cod (Gad m 1) IgE level

Up & Down
Allergen-specific immunotherapy for food allergy
Allergen-specific immunotherapy (oral, sublingual, epicutaneous, or subcutaneous) is the only disease-modifying treatment for food allergy and typically causes an early rise in allergen-specific IgE during build-up, followed by a gradual decline over months to years as tolerance develops. The reviewed trials studied milk, egg, and peanut rather than cod, and no fish-specific immunotherapy trials are available in the literature, so the magnitude and timing of changes for Gad m 1 specifically are not directly known; the pattern is expected to be similar based on shared IgE biology.
MedicationModerate Evidence
Decrease
Anti-IgE monoclonal antibody therapy (omalizumab)
Omalizumab binds free IgE in the blood and blocks it from triggering allergic responses, improving symptoms in food allergy and making allergen immunotherapy easier to tolerate. Reviews confirm clinical benefit but do not quantify how much Gad m 1 IgE itself moves on standard assays, since the drug acts on circulating IgE rather than on the antibody-producing cells directly.
MedicationModerate Evidence
Decrease
Strict avoidance of cod and cross-reactive fish
Strict avoidance is the standard of care for IgE-mediated fish allergy and prevents acute reactions, though the evidence reviewed does not quantify how much Gad m 1 IgE itself declines on avoidance alone. Some allergen-specific IgE levels drift downward over months to years without exposure, but a meaningful proportion of patients remain sensitized indefinitely.
LifestyleModest Evidence

Frequently Asked Questions

Panels containing Atlantic Cod (Gad m 1) IgE

Atlantic Cod (Gad m 1) IgE is included in these pre-built panels.

References

26 studies
  1. Marisa Espinazo Romeu, a. L. Camacho, C. Moreno Aguilar, Aurora Jurado Roger, F. Moreno BenítezClinical and Experimental Allergy2022
  2. Eric Franciskovic, Linnea Thörnqvist, L. Greiff, Maria Gasset, Mats OhlinFrontiers in Immunology2024
  3. S. G. Tedner, a. Asarnoj, H. Thulin, M. Westman, J. Konradsen, C. NilssonJournal of Internal Medicine2021
  4. M. Michelet, B. Balbino, L. Guilleminault, L. ReberEuropean Journal of Immunology2021
  5. A. Schoos, D. Bullens, B. Chawes, J. Costa, L. De Vlieger, a. Dunngalvin, M. Epstein, J. Garssen, C. Hilger, K. Knipping, a. Kuehn, D. Mijakoski, D. Munblit, Nikita a. Nekliudov, C. Ozdemir, Karine Patient, D. Peroni, S. Stoleski, E. Stylianou, Mirjana Tukalj, K. Verhoeckx, M. Zidarn, Willem Van De VeenFrontiers in Immunology2020